{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:20:14Z","timestamp":1790893214057,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T12:12:43Z","timestamp":1692187963000},"page":"702.e1-702.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)"],"prefix":"10.1016","volume":"29","author":[{"given":"Victor","family":"Gal\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-6557","authenticated-orcid":false,"given":"Cristina","family":"Bel\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-4091","authenticated-orcid":false,"given":"Carlos","family":"Echecopar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-1763","authenticated-orcid":false,"given":"Pablo","family":"Estival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sissini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3275-4192","authenticated-orcid":false,"given":"Raquel","family":"Olivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-8384","authenticated-orcid":false,"given":"Isabel","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Margarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rif\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Urtasun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edaz de Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Fern\u00e1ndez Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonz\u00e1lez-Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7215-9403","authenticated-orcid":false,"given":"Beatriz","family":"Ruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.016_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00066-021-01810-4","article-title":"Total body irradiation as part of conditioning regimens in childhood leukemia-long-term outcome, toxicity, and secondary malignancies","volume":"198","author":"Gruen","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bmt.2011.88","article-title":"Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike","volume":"47","author":"Danylesko","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.08.016_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.775485","article-title":"Total body irradiation forever? Optimising chemotherapeutic options for irradiation-free conditioning for paediatric acute lymphoblastic leukaemia","volume":"9","author":"Ben Hassine","year":"2021","journal-title":"Front Pediatr."},{"key":"10.1016\/j.jtct.2023.08.016_bib0005","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.bbmt.2019.05.005","article-title":"Gonadal function after busulfan compared with treosulfan in children and adolescents undergoing allogeneic hematopoietic stem cell transplant","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0006","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41409-022-01755-x","article-title":"Late endocrine effects after hematopoietic stem cell transplantation in children with non-malignant diseases","volume":"57","author":"de Kloet","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0007","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoitic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0008","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Summary of opinion (post authorisation) Trecondi treosulfan. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/summaries-opinion\/trecondi-0. Accessed January 26, 2023."},{"key":"10.1016\/j.jtct.2023.08.016_bib0009","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.016_bib0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.016_bib0011","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.016_bib0012","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/ejh.13536","article-title":"Haploidentical transplantation in pediatric non-malignant diseases: a retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH)","volume":"106","author":"Torres Canizales","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.htct.2022.05.008","article-title":"Immune reconstitution after allogenic stem cell transplantation: an observational study in pediatric patients","volume":"45","author":"Belinovski","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.016_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pcl.2009.11.007","article-title":"Management of acute graft-versus-host disease in children","volume":"57","author":"Carpenter","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jtct.2023.08.016_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0016","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0017","first-page":"1141","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","author":"Gray","year":"198816","journal-title":"Ann Stat."},{"key":"10.1016\/j.jtct.2023.08.016_bib0018","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.08.016_bib0019","doi-asserted-by":"crossref","first-page":"e14233","DOI":"10.1111\/petr.14233","article-title":"HSCT with mismatched unrelated donors: bone marrow versus peripheral blood stem cells sources in pediatric patients","volume":"26","author":"Berger","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0020","doi-asserted-by":"crossref","first-page":"e28079","DOI":"10.1002\/pbc.28079","article-title":"The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Friend","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.08.016_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.591363","article-title":"Long-term outcomes of treosulfan- versus busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myeloid leukemia before hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.jtct.2023.08.016_bib0022","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/bjh.12737","article-title":"Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients","volume":"165","author":"Dedeken","year":"2014","journal-title":"Br J Haematol."},{"key":"10.1016\/j.jtct.2023.08.016_bib0023","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.cad.0000231482.15277.48","article-title":"Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes","volume":"17","author":"Zwaveling","year":"2006","journal-title":"Anticancer Drugs."},{"key":"10.1016\/j.jtct.2023.08.016_bib0024","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00277-021-04732-4","article-title":"Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major","volume":"101","author":"L\u00fcftinger","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.07.020","article-title":"Survival advantage of treosulfan plus fludarabine before allogeneic hematopoietic cell transplantation for older or comorbid patients with myeloid malignancies","volume":"27","author":"Sakellari","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.016_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/08880018.2020.1738604","article-title":"Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens","volume":"37","author":"Huttunen","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0027","doi-asserted-by":"crossref","first-page":"e13626","DOI":"10.1111\/petr.13626","article-title":"Molho-Pessach V. Skin toxicity following treosulfan-thiotepa-fludarabine-based conditioning regimen in non-malignant pediatric patients undergoing hematopoietic stem cell transplantation","volume":"24","author":"Even-Or","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.09.018","article-title":"Impact of treosulfan exposure on early and long-term clinical outcomes in pediatric allogeneic hematopoietic stem cell transplantation recipients: a prospective multicenter study","volume":"28","author":"van der Stoep","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.016_bib0029","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cpt.1715","article-title":"Proposed therapeutic range of treosulfan in reduced toxicity pediatric allogeneic hematopoietic stem cell transplant conditioning: results from a prospective trial","volume":"108","author":"Chiesa","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtct.2023.08.016_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2015.343","article-title":"TCR-alpha\/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia","volume":"51","author":"Maschan","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.08.016_bib0031","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bbmt.2018.04.025","volume":"24","author":"Nemecek","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/pbc.25764","article-title":"European Society for Blood and Marrow Transplantation analysis of treosulfan conditioning before hematopoietic stem cell transplantation in children and adolescents with hematological malignancies","volume":"63","author":"Boztug","year":"2016","journal-title":"Pediatr Blood Cancer."},{"key":"10.1016\/j.jtct.2023.08.016_bib0033","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41409-020-0869-6","article-title":"Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies","volume":"55","author":"Kalwak","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.08.016_bib0034","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1200\/JCO.21.01942","article-title":"High-dose treosulfan and melphalan as consolidation therapy versus standard therapy for high-risk (metastatic) Ewing sarcoma","volume":"40","author":"Koch","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00277-014-2196-8","article-title":"Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia","volume":"94","author":"Boztug","year":"2015","journal-title":"Ann Hematol."},{"key":"10.1016\/j.jtct.2023.08.016_bib0036","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2141.2012.09228.x","article-title":"Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia","volume":"159","author":"Corker","year":"2012","journal-title":"Br J Haematol."},{"key":"10.1016\/j.jtct.2023.08.016_bib0037","doi-asserted-by":"crossref","first-page":"e27010","DOI":"10.1002\/pbc.27010","article-title":"Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning","volume":"65","author":"Shadur","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.08.016_bib0038","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ejh.13828","article-title":"A retrospective study of treosulfan versus busulfan-based conditioning in pediatric patients","volume":"109","author":"Olivas-Maz\u00f3n","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0039","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","article-title":"Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience","volume":"24","author":"Slatter","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.08.016_bib0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbmt.2014.08.020","article-title":"Treosulfan-based conditioning and hematopoietic cell transplantation for non-malignant diseases: a prospective multicenter trial","volume":"20","author":"Burroughs","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0041","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjh.13352","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease","volume":"169","author":"Strocchio","year":"2015","journal-title":"Br J Haematol."},{"key":"10.1016\/j.jtct.2023.08.016_bib0042","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3324\/haematol.2013.094730","article-title":"Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis","volume":"99","author":"Lehmberg","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.08.016_bib0043","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.016_bib0044","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.bbmt.2017.06.002","article-title":"Allogeneic hematopoietic cell transplantation using treosulfan-based conditioning for treatment of marrow failure disorders","volume":"23","author":"Burroughs","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.016_bib0045","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood.2021014687","article-title":"Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis","volume":"139","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.016_bib0046","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10875-021-01200-6","article-title":"Hematopoietic cell transplant for CD40 ligand deficiency-comparing busulfan versus treosulfan","volume":"42","author":"Carruthers","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2023.08.016_bib0047","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","article-title":"Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children","volume":"19","author":"Bartelink","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:09:11Z","timestamp":1763003351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723014732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723014732"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.016","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}